A Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir (Tamiflu) in Patients in the Intensive Care Unit

Trial Profile

A Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir (Tamiflu) in Patients in the Intensive Care Unit

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2010

At a glance

  • Drugs Oseltamivir; Oseltamivir
  • Indications Influenza virus infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Apr 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 19 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top